CN Patent
CN109384717A — 5,7-二氯-1,2,3,4-四氢异喹啉-6-甲酸盐酸盐水合物及其制备方法和用途
Assigned to Guang'an Kate Pharmaceutical Co Ltd · Expires 2019-02-26 · 7y expired
What this patent protects
本发明公开了一种5,7‑二氯‑1,2,3,4‑四氢异喹啉‑6‑甲酸盐酸盐水合物,如式(I)所示。其该晶型以2θ±0.2°衍射角表示的X‑射线粉末衍射谱图在8.0、21.3、24.2、25.2、34.2、36.4、38.6处显示特征峰。该晶型具有良好的稳定性。
USPTO Abstract
本发明公开了一种5,7‑二氯‑1,2,3,4‑四氢异喹啉‑6‑甲酸盐酸盐水合物,如式(I)所示。其该晶型以2θ±0.2°衍射角表示的X‑射线粉末衍射谱图在8.0、21.3、24.2、25.2、34.2、36.4、38.6处显示特征峰。该晶型具有良好的稳定性。
Drugs covered by this patent
- Xiidra (LIFITEGRAST) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.